Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.4.3.4 extracted from

  • Chen, J.J.; Swope, D.M.; Dashtipour, K.
    Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinsons disease (2007), Clin. Ther., 29, 1825-1849.
    View publication on PubMed

Application

Application Comment Organism
medicine the monoamine oxidase B inhibitor N-propargyl-l(R)-aminoindan (i.e. rasagiline) is well tolerated and effective in the treatment of early Parkinson's disease and as adjunctive treatment in levodopa-treated patients with Parkinson's disease experiencing motor fluctuations Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
N-propargyl-l(R)-aminoindan i.e. rasagiline. N-Propargyl-l(R)-aminoindan is well tolerated and effective in the treatment of early Parkinson's disease and as adjunctive treatment in levodopa-treated patients with Parkinson's disease experiencing motor fluctuations Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P27338
-
-

Synonyms

Synonyms Comment Organism
MAO type B
-
Homo sapiens
MAO-B
-
Homo sapiens